The Vanguard Group 13D and 13G filings for Twist Bioscience Corporation:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2024-02-13 5:15 pm Sale | 2023-12-29 | 13G | Twist Bioscience Corporation TWST | The Vanguard Group | 5,475,322 9.490% | -222,225 (-3.90%) | Filing |
| 2023-04-10 1:39 pm Purchase | 2023-03-31 | 13G | Twist Bioscience Corporation TWST | The Vanguard Group | 5,697,547 10.020% | 468,202 (+8.95%) | Filing |
| 2023-02-09 11:35 am Purchase | 2022-12-30 | 13G | Twist Bioscience Corporation TWST | The Vanguard Group | 5,229,345 9.240% | 905,737 (+20.95%) | Filing |
| 2022-02-10 08:42 am Purchase | 2021-12-31 | 13G | Twist Bioscience Corporation TWST | The Vanguard Group | 4,323,608 8.710% | 800,222 (+22.71%) | Filing |
| 2021-02-10 11:57 am Purchase | 2020-12-31 | 13G | Twist Bioscience Corporation TWST | The Vanguard Group | 3,523,386 7.310% | 3,523,386 (New Position) | Filing |